Whether your personal interests are in supporting innovation, bringing lifesaving biomedical products to patients, training the next generation of biomedical leaders or fueling our economy, the Center for Biotechnology provides a vehicle to accomplish great things. Things that matter. Things that change, and save, lives.
Your involvement is an essential part of our future. Please consider a gift to the Center for Biotechnology which will help fuel innovation by ensuring that lifesaving technologies make it out of research labs and into the hands of patients.
Give to the Center for Biotechnology online through the Stony Brook Foundation. Contributions can be made to our Fund for Excellence. More information about donating through the Stony Brook Foundation can be found here.
Join us at the Stony Brook University Incubator Company Showcase at CEWIT on June 2nd ! A joint effort by Stony Brook University’s Centers of Excellence, Centers for Advanced Technology, Business Incubators and Development Centers, the event showcases one of the nation’s most comprehensive suite of economic development programs and the technological innovations and entrepreneurial advances of the University’s burgeoning community of member companies.
The Incubator Company Showcase will feature over 40 company exhibits and displays. Providing ample time for valuable networking and one-on-one conversations with our scope of biotechnology, energy and information technology companies. The event will also commemorate both the graduation and homegrown success of Codagenix, Inc.
The Center for Biotechnology has announced the recipients of the 2016-2017 Applied Research & Development (ARAD) awards. The ARAD Program is designed to help bridge the gap between the early-stage technology discovery and development capabilities of the academic community and the later-stage commercial development interests of the bioscience industry.
The program currently provides matching funds on a competitive basis to support collaborations between Stony Brook University faculty and NY State corporate partners in all areas of medical biotechnology. The primary interest is in supporting development of technologies that will help companies hit commercially relevant milestones, and that have the potential to positively impact the New York State economy. The projects funded include:
ICU Temporary Pacemaker – Dr. Wei Lin and Avery Biomedical Device, Inc.
Novel Synergistic and Pleiotropic Skin Brightening Agents – Dr. Sanford Simon and Biocogent, LLC
Continued In vivo Testing of Vaccine Candidates – Dr. Eckard Wimmer and Cogadenix, Inc.
Advanced Fistula-in-Ano Treatment Device – Dr. Tom Zimmerman and Pepper5, Inc.
Development of Nanoemulsion-PUFA-taxoids as Tumor-Targeted Chemotherapeutics – Dr. Iwao Ojima and TargaGenix, Inc.
Initial Pre-Clinical Safety Assessment of TRB-N0224 – Dr. Lorne Golub and Traverse Biosciences, Inc.
Evaluation of a Continuous Visible Light Disinfection System’s Ability to Reduce Bioburden and Subsequently the Incidence of Infections and Colonizations in an Active Patient Area – Dr. Annie Rohan and Vital Vio, Inc.
More information about the Applied Research & Development (ARAD) program, as well as all Center for Biotechnology Technology Development programs can be found here.
Codagenix, a Stony Brook biotech company, has closed on $322,000 in public and private funding, including the latest investment from Accelerate Long Island and the Long Island Emerging Technologies Fund. Read more about the company and the funding from Accelerate Long Island and Newsday.com.